ロード中...
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
Hormonal deprivation therapy is well established for the treatment of locally advanced and metastatic prostate cancer, as well as the adjuvant treatment of some patients with localized disease. Long-acting gonadotropin releasing hormone (GnRH) agonists have become a mainstay of androgen deprivation...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2697591/ https://ncbi.nlm.nih.gov/pubmed/19554097 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|